rs7179432

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000626874.2(CHD2):​c.*1417T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.451 in 152,016 control chromosomes in the GnomAD database, including 16,681 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 16680 hom., cov: 32)
Exomes 𝑓: 1.0 ( 1 hom. )

Consequence

CHD2
ENST00000626874.2 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.295

Publications

6 publications found
Variant links:
Genes affected
CHD2 (HGNC:1917): (chromodomain helicase DNA binding protein 2) The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CHD2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy 94
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myoclonic-astatic epilepsy
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.874 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHD2NM_001271.4 linkc.5153+1484T>C intron_variant Intron 38 of 38 ENST00000394196.9 NP_001262.3 O14647-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHD2ENST00000626874.2 linkc.*1417T>C 3_prime_UTR_variant Exon 38 of 38 1 ENSP00000486629.1 O14647-2
CHD2ENST00000394196.9 linkc.5153+1484T>C intron_variant Intron 38 of 38 5 NM_001271.4 ENSP00000377747.4 O14647-1
CHD2ENST00000625662.3 linkn.*1324+1484T>C intron_variant Intron 34 of 34 5 ENSP00000486007.2 A0A0D9SEU0
CHD2ENST00000627460.1 linkn.*285+1484T>C intron_variant Intron 4 of 4 5 ENSP00000485982.1 A0A0D9SET4

Frequencies

GnomAD3 genomes
AF:
0.451
AC:
68558
AN:
151896
Hom.:
16666
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.322
Gnomad AMI
AF:
0.405
Gnomad AMR
AF:
0.511
Gnomad ASJ
AF:
0.381
Gnomad EAS
AF:
0.896
Gnomad SAS
AF:
0.587
Gnomad FIN
AF:
0.602
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.455
Gnomad OTH
AF:
0.441
GnomAD4 exome
AF:
1.00
AC:
2
AN:
2
Hom.:
1
Cov.:
0
AC XY:
0
AN XY:
0
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AF:
1.00
AC:
2
AN:
2

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.451
AC:
68594
AN:
152014
Hom.:
16680
Cov.:
32
AF XY:
0.462
AC XY:
34345
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.321
AC:
13320
AN:
41448
American (AMR)
AF:
0.512
AC:
7823
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.381
AC:
1320
AN:
3464
East Asian (EAS)
AF:
0.896
AC:
4647
AN:
5188
South Asian (SAS)
AF:
0.585
AC:
2816
AN:
4814
European-Finnish (FIN)
AF:
0.602
AC:
6338
AN:
10536
Middle Eastern (MID)
AF:
0.299
AC:
88
AN:
294
European-Non Finnish (NFE)
AF:
0.455
AC:
30927
AN:
67966
Other (OTH)
AF:
0.448
AC:
947
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1818
3636
5455
7273
9091
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
632
1264
1896
2528
3160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.443
Hom.:
33013
Bravo
AF:
0.437
Asia WGS
AF:
0.700
AC:
2434
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
4.1
DANN
Benign
0.72
PhyloP100
-0.29
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7179432; hg19: chr15-93564972; API